Pages that link to "Q38747746"
Jump to navigation
Jump to search
The following pages link to Glioma Subclassifications and Their Clinical Significance. (Q38747746):
Displaying 43 items.
- AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma (Q41721700) (← links)
- Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients (Q47097853) (← links)
- MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells (Q47107443) (← links)
- Protein Phosphatase Magnesium-Dependent 1δ (PPM1D) Expression as a Prognostic Marker in Adult Supratentorial Diffuse Astrocytic and Oligodenroglial Tumors. (Q47631527) (← links)
- From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence (Q47863423) (← links)
- Nucleolar and spindle-associated protein 1 is a tumor grade correlated prognosis marker for glioma patients. (Q48238113) (← links)
- BAF53a is a potential prognostic biomarker and promotes invasion and epithelial-mesenchymal transition of glioma cells (Q49167080) (← links)
- An intronic genetic variation of affects enhancer activity and is associated with glioma susceptibility (Q57490699) (← links)
- Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity (Q60957169) (← links)
- Boron delivery agents for neutron capture therapy of cancer (Q89141802) (← links)
- Amentoflavone suppresses cell proliferation and induces cell death through triggering autophagy-dependent ferroptosis in human glioma (Q89713359) (← links)
- Expression and prognostic value of long non-coding RNA H19 in glioma via integrated bioinformatics analyses (Q89818679) (← links)
- Meningeal lymphatic vessels regulate brain tumor drainage and immunity (Q89866258) (← links)
- Structural and Functional Alterations in the Contralesional Medial Temporal Lobe in Glioma Patients (Q90175818) (← links)
- Discovery of a Ruthenium Complex for the Theranosis of Glioma through Targeting the Mitochondrial DNA with Bioinformatic Methods (Q90225837) (← links)
- TNFα inhibitor C87 sensitizes EGFRvIII transfected glioblastoma cells to gefitinib by a concurrent blockade of TNFα signaling (Q90357724) (← links)
- Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma (Q90409700) (← links)
- Advances in Non-invasive Neurodiagnostics (Q90477429) (← links)
- 3D extracellular matrix microenvironment in bioengineered tissue models of primary pediatric and adult brain tumors (Q90496567) (← links)
- NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas (Q90642101) (← links)
- Polyphyllin VI Induces Apoptosis and Autophagy via Reactive Oxygen Species Mediated JNK and P38 Activation in Glioma (Q90669161) (← links)
- VHA Practice Guideline Recommendations for Diffuse Gliomas (Q91600817) (← links)
- Integrated Transcriptome Analyses and Experimental Verifications of Mesenchymal-Associated TNFRSF1A as a Diagnostic and Prognostic Biomarker in Gliomas (Q91649930) (← links)
- Challenges of targeting BRAF V600E mutations in adult primary brain tumor patients: a report of two cases (Q91818329) (← links)
- Transcriptomic Analysis of Glioma Based on IDH Status Identifies ACAA2 as a Prognostic Factor in Lower Grade Glioma (Q91843726) (← links)
- A novel circular RNA circENTPD7 contributes to glioblastoma progression by targeting ROS1 (Q92061752) (← links)
- Potential for Nuclear Medicine Therapy for Glioblastoma Treatment (Q92237972) (← links)
- ABC Transporters at the Blood-Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas (Q92257741) (← links)
- A Risk Classification System With Five-Gene for Survival Prediction of Glioblastoma Patients (Q92403994) (← links)
- In silico Design of Novel Histone Deacetylase 4 Inhibitors: Design Guidelines for Improved Binding Affinity (Q92441031) (← links)
- Detection and Correlation of Single and Concomitant TP53, PTEN, and CDKN2A Alterations in Gliomas (Q92445464) (← links)
- Upregulation of miR-340 Inhibits Tumor Growth and Mesenchymal Transition via Targeting c-MET in Glioblastoma (Q96133082) (← links)
- Knockdown of the long noncoding RNA XIST suppresses glioma progression by upregulating miR-204-5p (Q96135385) (← links)
- PD-L1 Expression in Glioblastoma, the Clinical and Prognostic Significance: A Systematic Literature Review and Meta-Analysis (Q97525213) (← links)
- Role of molecular biomarkers in glioma resection: a systematic review (Q99406309) (← links)
- Improving human cancer therapy through the evaluation of pet dogs (Q99551380) (← links)
- The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis (Q99591931) (← links)
- IFI30 expression is an independent unfavourable prognostic factor in glioma (Q99618671) (← links)
- Long non-coding RNA LBX2-AS1 enhances glioma proliferation through downregulating microRNA-491-5p (Q99629843) (← links)
- Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Model for Lower-Grade Glioma (Q99711989) (← links)
- LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1 (Q101133575) (← links)
- Bevacizumab Combined with Intensity-Modulated Radiation Therapy on Cognitive and Coagulation Function in Postoperative Glioma Patients (Q112414288) (← links)
- miR-190a-3p Promotes Proliferation and Migration in Glioma Cells via YOD1 (Q112750460) (← links)